Mosaic ImmunoEngineering (CPMV) Accounts Payables (2011 - 2026)
Mosaic ImmunoEngineering (CPMV) posted quarterly Accounts Payables of $167058.0 for Q1 2026, up 20.94% year-over-year from $138129.0 in Q1 2025, and up 25.81% quarter-over-quarter from $132784.0 in Q4 2025.
Mosaic ImmunoEngineering (CPMV) Accounts Payables (2011 - 2026) Analysis & Trends
Mosaic ImmunoEngineering's Accounts Payables history runs 16 years deep, the most recent figure standing at $167058.0 for Q1 2026.
- In Q1 2026, Accounts Payables rose 20.94% year-over-year to $167058.0; the TTM figure through Mar 2026 stood at $167058.0 (up 20.94% YoY), while the FY2025 annual figure was $132784.0, down 1.54% from the prior year.
- Accounts Payables for Q1 2026 stood at $167058.0, up from $132784.0 in the prior quarter.
- The five-year high for Accounts Payables was $167058.0 in Q1 2026, with the low at $116421.0 in Q3 2023.
- The 5-year median for Accounts Payables is $132784.0 (2025), against an average of $132025.1.
- The sharpest annual moves came in 2022 and 2023: Accounts Payables surged 79.25% in 2022, then retreated 11.23% in 2023.
- Mosaic ImmunoEngineering's Accounts Payables stood at $133464.0 in 2022, then retreated by 11.23% to $118478.0 in 2023, then grew by 13.83% to $134865.0 in 2024, then fell by 1.54% to $132784.0 in 2025, then rose by 25.81% to $167058.0 in 2026.
- Business Quant data shows CPMV's Accounts Payables at $167058.0 in Q1 2026, $132784.0 in Q4 2025, and $133759.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 35.57 Mn |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | 167,058.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 167,058.00 |
| Dec 31, 2025 | 132,784.00 |
| Sep 30, 2025 | 133,759.00 |
| Jun 30, 2025 | 133,808.00 |
| Mar 31, 2025 | 138,129.00 |
| Dec 31, 2024 | 134,865.00 |
| Sep 30, 2024 | 143,618.00 |
| Jun 30, 2024 | 125,040.00 |
| Mar 31, 2024 | 129,451.00 |
| Dec 31, 2023 | 118,478.00 |
| Sep 30, 2023 | 116,421.00 |
| Jun 30, 2023 | 131,076.00 |
| Mar 31, 2023 | 127,910.00 |
| Dec 31, 2022 | 133,464.00 |
| Sep 30, 2022 | 121,283.00 |
| Jun 30, 2022 | 123,889.00 |
| Mar 31, 2022 | 133,393.00 |
| Dec 31, 2021 | 113,513.00 |
| Sep 30, 2021 | 114,296.00 |
| Jun 30, 2021 | 69,115.00 |